Evkeeza is a medicine used together with low-fat diet and other medicines to reduce levels of cholesterol in the blood. It is used in adults, adolescents and children aged 6 months and older with homozygous familial hypercholesterolaemia. This is an inherited disease that increases the levels of low-density lipoprotein cholesterol (LDL cholesterol or ‘bad cholesterol’) in the blood, which is a known risk factor for cardiovascular disease. Evkeeza contains the active substance evinacumab.
Therapeutic Indication
### Therapeutic indication Evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (HoFH).
Therapeutic Area (MeSH)
ATC Code
C10AX
ATC Item
其它血脂调节剂
Pharmacotherapeutic Group
Lipid modifying agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Evinacumab | N/A | 依维库单抗 |
EMA Name
Evkeeza
Medicine Name
Evkeeza
Aliases
N/A
